Mark Hurley

Mark Hurley has extensive experience as a chair and non-executive director in various organizations. Mark is currently serving in this capacity at e-bate Limited since September 2021.

In 2008, Mark Hurley joined Biofortuna Limited and held the role of chair and non-executive director. Mark played a significant role in establishing Biofortuna as a trusted outsourcing partner for genomic services, custom development, and contract manufacturing services.

From 2017, Mark Hurley has been chair and non-executive director at e2E Satellite Communications. Mark provided guidance and leadership in the satellite communications industry.

Mark Hurley also served as chair and non-executive director at The Local Data Company starting from 2013. Mark contributed to the company's delivery of comprehensive insights on the UK retail and leisure landscape.

In 2014, Mark Hurley took on the role of chair and non-executive director at Intechnica, specializing in IT performance solutions. Mark played a key role in raising investment capital for the company.

Mark Hurley served as chair and non-executive director at Origin Broadband Limited from 2016 to 2019. Mark played a crucial role in the company's growth with its award-winning broadband services.

In 2010, Mark Hurley led a buy-out of BioEDEN Limited and held the position of chair and non-executive director. Mark contributed to the development and expansion of the world's first international biobank company that collects and stores living tooth cells.

Starting in 2009, Mark Hurley was chair and non-executive director at Novolytics Limited, a company focused on combating antibacterial resistance. Mark guided the development and launch of products targeting hospital superbugs.

From 2004 to 2014, Mark Hurley served as a non-executive director at Spear Therapeutics Limited, specializing in small molecule drug design for cancer treatment.

In 2008, Mark Hurley was a non-executive director at Ulive plc, where they played a role in identifying and commercializing intellectual property owned by the University of Liverpool.

Overall, Mark Hurley has a wealth of experience in leadership positions, particularly in the fields of genomic services, IT performance, broadband services, biobanking, antibacterial resistance, and cancer treatment.

Mark Hurley has received education from various institutions, with no specific years mentioned. However, no degree or field of study information is available for these educational experiences.